These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 22391675)
21. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Bays H Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765 [TBL] [Abstract][Full Text] [Related]
22. [A comparative study of the effectiveness of topiramate and flunarizine in independent series of chronic migraine patients without medication abuse]. Gracia-Naya M; Ríos C; García-Gomara MJ; Sánchez-Valiente S; Mauri-Llerda JÁ; Santos-Lasaosa S; Artal-Roy J; Latorre-Jiménez AM Rev Neurol; 2013 Oct; 57(8):347-53. PubMed ID: 24081889 [TBL] [Abstract][Full Text] [Related]
23. [Changes of body weight and galanin in epileptic children treated with topiramate]. Shi RF; Wang KL; Li QH; Zheng HC; Yang HF; Tang HX; Sun SZ; Wang LH; Tian J Zhonghua Er Ke Za Zhi; 2007 Mar; 45(3):199-202. PubMed ID: 17504624 [TBL] [Abstract][Full Text] [Related]
24. Topiramate for weight reduction in adolescents with severe obesity. Fox CK; Marlatt KL; Rudser KD; Kelly AS Clin Pediatr (Phila); 2015 Jan; 54(1):19-24. PubMed ID: 25027265 [TBL] [Abstract][Full Text] [Related]
25. Influence of topiramate in the regulation of energy balance. Richard D; Ferland J; Lalonde J; Samson P; Deshaies Y Nutrition; 2000 Oct; 16(10):961-6. PubMed ID: 11054602 [TBL] [Abstract][Full Text] [Related]
26. Resource use associated with topiramate in migraine prophylaxis. Feliu AL; Rupnow MF; Blount A; Boccuzzi SJ; Vermilyea J Am J Health Syst Pharm; 2007 Jul; 64(14):1483-91. PubMed ID: 17617498 [TBL] [Abstract][Full Text] [Related]
27. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study. Mathew NT; Jaffri SF Headache; 2009; 49(10):1466-78. PubMed ID: 19912346 [TBL] [Abstract][Full Text] [Related]
28. The impact of topiramate on health-related quality of life indicators in chronic migraine. Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ Headache; 2007; 47(10):1398-408. PubMed ID: 18052949 [TBL] [Abstract][Full Text] [Related]
29. Effects of topiramate on migraine frequency and cortical excitability in patients with frequent migraine. Artemenko AR; Kurenkov AL; Filatova EG; Nikitin SS; Kaube H; Katsarava Z Cephalalgia; 2008 Mar; 28(3):203-8. PubMed ID: 18254890 [TBL] [Abstract][Full Text] [Related]
30. Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Mathew NT; Kailasam J; Meadors L Headache; 2002 Sep; 42(8):796-803. PubMed ID: 12390644 [TBL] [Abstract][Full Text] [Related]
31. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial. Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J; Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947 [TBL] [Abstract][Full Text] [Related]
32. [Preventive treatment with topiramate enhances the quality of life of patients with migraine]. Medrano V; Sempere AP; Morera-Guitart J; Fernandez-Izquierdo S; Espinosa-Martinez J Rev Neurol; 2006 Sep 1-15; 43(5):259-63. PubMed ID: 16941422 [TBL] [Abstract][Full Text] [Related]
33. Topiramate in the preventive treatment of episodic migraine: a combined analysis from pilot, double-blind, placebo-controlled trials. Edwards KR; Potter DL; Wu SC; Kamin M; Hulihan J CNS Spectr; 2003 Jun; 8(6):428-32. PubMed ID: 12858132 [TBL] [Abstract][Full Text] [Related]
34. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache. Limmroth V; Biondi D; Pfeil J; Schwalen S Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of topiramate and valproate in chronic migraine. Bartolini M; Silvestrini M; Taffi R; Lanciotti C; Luconi R; Capecci M; Provinciali L Clin Neuropharmacol; 2005; 28(6):277-9. PubMed ID: 16340383 [TBL] [Abstract][Full Text] [Related]
36. Analysis of pooled data from two pivotal controlled trials on the efficacy of topiramate in the prevention of migraine. Freitag FG; Forde G; Neto W; Wang DZ; Schmitt J; Wu SC; Hulihan J J Am Osteopath Assoc; 2007 Jul; 107(7):251-8. PubMed ID: 17682112 [TBL] [Abstract][Full Text] [Related]
38. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis. Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129 [TBL] [Abstract][Full Text] [Related]
39. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain. Pascual J; Sánchez del Rio M; Mateos V; Láinez JM; Hernández-Gallego J; Leira R; Jiménez MD Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244 [TBL] [Abstract][Full Text] [Related]
40. A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: a pilot study. Lewis D; Paradiso E Headache; 2007; 47(10):1409-17. PubMed ID: 18052950 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]